Christopher P. Acevedo
Chief Financial Officer at OS Therapies.
- Grasonville, MD
- Form D signer
- OS Therapies
Raised on OS Therapies filings
$11.6M
of $19.2M offered across 4 Form D filings
- Form D filings
- 4
- Teammates
- 1
- Last filing
- Jul 16, 2026
Company
HER2-targeted immunotherapy for osteosarcoma
- Investors
- 9
- Still open
- $7.7M
OS Therapies filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 16, 2026 | Security to be acquired | $1.6M/ $9.3M | Form D |
| Mar 6, 2026 | Security to be acquired | $2M/ $2M | Form D |
| Sep 10, 2025 | Equity | $3.8M/ $3.8M | Form D |
| Jul 16, 2025 | Equity | $4.2M/ $4.2M | Form D |
